Research Paper Volume 15, Issue 20 pp 11588—11610

Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma

class="figure-viewer-img"

Figure 10. Correlation between tumor mutational burden (TMB), minicellular instability (MSI), and signature. (A, B) Waterfall plots of somatic mutations in low- and high-risk groups, respectively. (C, D) Survival analysis of different tumor mutational burden (TMB) and risk groups. (E) Scatter plot of the association of TMB with gene cluster-based risk scores. (F) Analysis of TMB to compare whether there was a difference in TMB of patients in high- and low-risk groups. (G, H) Correlation analysis of MSI with risk scores.